Cellular oncogenes and suppressor genes as prognostic markers in cancer
- 1 December 1993
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 26 (6) , 439-447
- https://doi.org/10.1016/0009-9120(93)80007-h
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapseEuropean Journal Of Cancer, 1992
- c‐erbB‐2 and ras expression levels in breast cancer are correlated and show a co‐operative association with unfavorable clinical outcomeInternational Journal of Cancer, 1991
- The H-ras oncogene product p21 and prognosis in human breast cancerBreast Cancer Research and Treatment, 1991
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.Journal of Clinical Investigation, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985